Boffa, Angelo
Di Martino, Alessandro
Andriolo, Luca
De Filippis, Roberto
Poggi, Alberto https://orcid.org/0000-0003-3569-7672
Kon, Elizaveta
Zaffagnini, Stefano
Filardo, Giuseppe
Article History
Received: 9 August 2021
Accepted: 25 October 2021
First Online: 12 November 2021
Declarations
:
: EK reports consulting for Carihealldt, Green Bone, Geistlich, and Bioveex, and speaking for Zimmer Biomet and Fidia Farmaceutici SPA. SZ reports non-financial support from personal fees from I + SRL, grants from Grants from FidiaFarmaceutici SPA, Cartihealltd, IGEA clinical biophysics, BIOMET, and Kensey Nash, outside the submitted work. The funders had no role in the design of the study, in the collection, analyses, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results. The other authors declare no conflict of interest.
: This prospective double-blind RCT was approved by the Hospital Ethics Committee of the Rizzoli Orthopaedic Institute, Bologna, Italy (prot. n. 0001181). The trial was registered at clinicaltrials.gov (registration number NCT03110679) and was entirely conducted in a highly specialized referral center for orthopaedic pathologies.
: Not applicable.